Biggest News Aggregation in the World
📰 Additional Development News

Page 17 - Additional Development News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Additional Development. Real-time updates on events, politics, business and more.

Elder line (Help Age India): meeting of stakeholders held at Anantnag

 ANANTNAG : To make the functioning of National Helpline for Senior Citizens, Elder Line 14567 (implemented by HelpAge India in J&K), smooth and effective in the district, a meeting of officers and stakeholders was held today under the chair
Jammu And Kashmir Bashir Ahmad Dar National Helpline For Senior Citizens Additional Development National Helpline Senior Citizens

Adagio Therapeutics Announces ADG20 (adintrevimab) is the First Monoclonal Antibody to Meet Primary Endpoints with Statistical Significance Across Pre- and Post-exposure Prophylaxis and Treatment for COVID-19 and Plans to Seek U.S. Emergency Use Authorization

Risk of symptomatic COVID-19 was reduced by 71% compared to placebo in pre-exposure prophylaxis and 75% compared to placebo in post-exposure prophylaxis Risk of hospitalization or death in... | March 30, 2022
Ellie Hershberger Dan Budwick Monique Allaire David Hering Additional Development Adagio Therapeutics Inc

Adagio Therapeutics : Announces ADG20 (adintrevimab) is the First Monoclonal Antibody to Meet Primary Endpoints with Statistical Significance Across Pre- and Post-exposure Prophylaxis and Treatment for COVID-19 and Plans to Seek U.S. Emergency Use Authorization - Form 8-K

Adagio Therapeutics Announces ADG20 is the First Monoclonal Antibody to Meet Primary Endpoints with Statistical Significance Across Pre- and Post-exposure Prophylaxis and Treatment... | March 30, 2022
Ellie Hershberger Dan Budwick Monique Allaire David Hering Additional Development Adagio Therapeutics Inc

Adagio Therapeutics, Inc.: Adagio Therapeutics Announces ADG20 (adintrevimab) is the First Monoclonal Antibody to Meet Primary Endpoints with Statistical Significance Across Pre- and Post-exposure Prophylaxis and Treatment for COVID-19 and Plans to Seek U

Risk of symptomatic COVID-19 was reduced by 71% compared to placebo in pre-exposure prophylaxis and 75% compared to placebo in post-exposure prophylaxis Risk of hospitalization or death in participants
Ellie Hershberger Dan Budwick Monique Allaire David Hering Additional Development Adagio Therapeutics Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Progress of registration of unorganized workers on e-SHRAM Portal reviewed at Kulgam

 KULGAM : The Additional District Development Commissioner (ADDC) Kulgam, Riyaz Ahmad Sofi today convened a meeting of DLIC members and reviewed the progress of registration of unorganized workers on the e-SHRAM portal.The ADDC emphasized on the
Jammu And Kashmir Riyaz Ahmad Sofi Additional Development Additional District Development Additional District Development Commissioner Street Vendors

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science